Innovations and Leadership Updates in Biopharmaceutical Companies
03:48 Share

Calidi Biotherapeutics Inc. reported a reduced Q1 2025 net loss, highlighted FDA clearance for CLD-201, and announced key leadership additions. Doreen Dann shared expert tips on navigating Medicare on Studio 17 Live, showcasing her dedication to compassionate care. Tonix Pharmaceuticals Holding Corp. appointed Joseph Hand as General Counsel as they prepare for potential FDA approval of TNX-102 SL for fibromyalgia.